ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.

Sebastian Ochoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.